Literature DB >> 28522578

Mutated ASXL1 and number of somatic mutations as possible indicators of progression to chronic myelomonocytic leukemia of myelodysplastic syndromes with single or multilineage dysplasia.

Ana Valencia-Martinez1, Alessandro Sanna1, Erico Masala1, Elisa Contini2, Alice Brogi1,3, Antonella Gozzini1, Valeria Santini4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28522578      PMCID： PMC5685232          DOI： 10.3324/haematol.2017.166124

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  15 in total

1.  ETV6 and signaling gene mutations are associated with secondary transformation of myelodysplastic syndromes to chronic myelomonocytic leukemia.

Authors:  Eric Padron; Sean Yoder; Sateesh Kunigal; Tania Mesa; Jamie K Teer; Najla Al Ali; Mikkael A Sekeres; Jeffrey S Painter; Ling Zhang; Jeffrey Lancet; Jaroslaw P Maciejewski; Pearlie K Epling-Burnette; Eduardo Sotomayor; Rami S Komrokji; Alan F List
Journal:  Blood       Date:  2014-06-05       Impact factor: 22.113

2.  Myelodysplastic syndromes with monocytic component: hematologic and cytogenetic characterization.

Authors:  G M Rigolin; A Cuneo; M G Roberti; A Bardi; G Castoldi
Journal:  Haematologica       Date:  1997 Jan-Feb       Impact factor: 9.941

3.  Chronic myelomonocytic leukemia evolving from preexisting myelodysplasia shares many features with de novo disease.

Authors:  Sa A Wang; Naomi Galili; Jan Cerny; Eric Sechman; Su Sin Chen; Jerome Loew; Qin Liu; Oluwole Fadare; Robert Hasserjian; Dan Jones; Huma Qawi; Bruce Woda; Azra Raza
Journal:  Am J Clin Pathol       Date:  2006-11       Impact factor: 2.493

Review 4.  The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.

Authors:  Daniel A Arber; Attilio Orazi; Robert Hasserjian; Jürgen Thiele; Michael J Borowitz; Michelle M Le Beau; Clara D Bloomfield; Mario Cazzola; James W Vardiman
Journal:  Blood       Date:  2016-04-11       Impact factor: 22.113

5.  Prognostic score including gene mutations in chronic myelomonocytic leukemia.

Authors:  Raphaël Itzykson; Olivier Kosmider; Aline Renneville; Véronique Gelsi-Boyer; Manja Meggendorfer; Margot Morabito; Céline Berthon; Lionel Adès; Pierre Fenaux; Odile Beyne-Rauzy; Norbert Vey; Thorsten Braun; Torsten Haferlach; François Dreyfus; Nicholas C P Cross; Claude Preudhomme; Olivier A Bernard; Michaela Fontenay; William Vainchenker; Susanne Schnittger; Daniel Birnbaum; Nathalie Droin; Eric Solary
Journal:  J Clin Oncol       Date:  2013-05-20       Impact factor: 44.544

6.  ASXL1 and SETBP1 mutations and their prognostic contribution in chronic myelomonocytic leukemia: a two-center study of 466 patients.

Authors:  M M Patnaik; R Itzykson; T L Lasho; O Kosmider; C M Finke; C A Hanson; R A Knudson; R P Ketterling; A Tefferi; E Solary
Journal:  Leukemia       Date:  2014-04-03       Impact factor: 11.528

7.  Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML.

Authors:  Julia E Maxson; Jason Gotlib; Daniel A Pollyea; Angela G Fleischman; Anupriya Agarwal; Christopher A Eide; Daniel Bottomly; Beth Wilmot; Shannon K McWeeney; Cristina E Tognon; J Blake Pond; Robert H Collins; Basem Goueli; Stephen T Oh; Michael W Deininger; Bill H Chang; Marc M Loriaux; Brian J Druker; Jeffrey W Tyner
Journal:  N Engl J Med       Date:  2013-05-09       Impact factor: 91.245

8.  ASXL1 plays an important role in erythropoiesis.

Authors:  Hui Shi; Shohei Yamamoto; Mengyao Sheng; Jie Bai; Peng Zhang; Runze Chen; Shi Chen; Lihong Shi; Omar Abdel-Wahab; Mingjiang Xu; Yuan Zhou; Feng-Chun Yang
Journal:  Sci Rep       Date:  2016-06-29       Impact factor: 4.379

9.  Clinical and biological implications of driver mutations in myelodysplastic syndromes.

Authors:  Elli Papaemmanuil; Moritz Gerstung; Luca Malcovati; Sudhir Tauro; Gunes Gundem; Peter Van Loo; Chris J Yoon; Peter Ellis; David C Wedge; Andrea Pellagatti; Adam Shlien; Michael John Groves; Simon A Forbes; Keiran Raine; Jon Hinton; Laura J Mudie; Stuart McLaren; Claire Hardy; Calli Latimer; Matteo G Della Porta; Sarah O'Meara; Ilaria Ambaglio; Anna Galli; Adam P Butler; Gunilla Walldin; Jon W Teague; Lynn Quek; Alex Sternberg; Carlo Gambacorti-Passerini; Nicholas C P Cross; Anthony R Green; Jacqueline Boultwood; Paresh Vyas; Eva Hellstrom-Lindberg; David Bowen; Mario Cazzola; Michael R Stratton; Peter J Campbell
Journal:  Blood       Date:  2013-09-12       Impact factor: 22.113

10.  Landscape of genetic lesions in 944 patients with myelodysplastic syndromes.

Authors:  T Haferlach; Y Nagata; V Grossmann; Y Okuno; U Bacher; G Nagae; S Schnittger; M Sanada; A Kon; T Alpermann; K Yoshida; A Roller; N Nadarajah; Y Shiraishi; Y Shiozawa; K Chiba; H Tanaka; H P Koeffler; H-U Klein; M Dugas; H Aburatani; A Kohlmann; S Miyano; C Haferlach; W Kern; S Ogawa
Journal:  Leukemia       Date:  2013-11-13       Impact factor: 11.528
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.